Sarepta Therapeutics Inc. plummeted in early trading after reporting a second patient died of acute liver failure while being ...

By Christy Santhosh and Bhanvi Satija (Reuters) -Shares of Sarepta Therapeutics slumped 42% on Monday after a second patient who had received its gene therapy, Elevidys, died in a span of three months ...